Alliance Pharma Statistics
Total Valuation
Alliance Pharma has a market cap or net worth of GBP 231.09 million. The enterprise value is 326.07 million.
Market Cap | 231.09M |
Enterprise Value | 326.07M |
Important Dates
The next estimated earnings date is Friday, September 20, 2024.
Earnings Date | Sep 20, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Alliance Pharma has 540.57 million shares outstanding. The number of shares has increased by 0.12% in one year.
Shares Outstanding | 540.57M |
Shares Change (YoY) | +0.12% |
Shares Change (QoQ) | -0.24% |
Owned by Insiders (%) | 0.13% |
Owned by Institutions (%) | 75.30% |
Float | 455.22M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | 9.74 |
PS Ratio | 1.28 |
PB Ratio | 1.06 |
P/FCF Ratio | 7.52 |
PEG Ratio | 1.73 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 6.40, with an EV/FCF ratio of 10.62.
EV / Earnings | -9.84 |
EV / Sales | 1.80 |
EV / EBITDA | 6.40 |
EV / EBIT | 7.66 |
EV / FCF | 10.62 |
Financial Position
The company has a current ratio of 2.57, with a Debt / Equity ratio of 53.89.
Current Ratio | 2.57 |
Quick Ratio | 1.83 |
Debt / Equity | 53.89 |
Debt / EBITDA | 2.30 |
Debt / FCF | 3.82 |
Interest Coverage | 4.26 |
Financial Efficiency
Return on equity (ROE) is -13.71% and return on invested capital (ROIC) is 7.21%.
Return on Equity (ROE) | -13.71% |
Return on Assets (ROA) | 5.76% |
Return on Capital (ROIC) | 7.21% |
Revenue Per Employee | 618,767 |
Profits Per Employee | -113,479 |
Employee Count | 292 |
Asset Turnover | 0.39 |
Inventory Turnover | 3.03 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -14.29% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | -14.29% |
50-Day Moving Average | 36.86 |
200-Day Moving Average | 37.67 |
Relative Strength Index (RSI) | 74.39 |
Average Volume (20 Days) | 1,328,505 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Alliance Pharma had revenue of GBP 180.68 million and -33.14 million in losses. Loss per share was -0.06.
Revenue | 180.68M |
Gross Profit | 105.02M |
Operating Income | 42.56M |
Pretax Income | -48.80M |
Net Income | -33.14M |
EBITDA | 50.23M |
EBIT | 42.56M |
Loss Per Share | -0.06 |
Balance Sheet
The company has 22.44 million in cash and 117.42 million in debt, giving a net cash position of -94.98 million or -0.18 per share.
Cash & Cash Equivalents | 22.44M |
Total Debt | 117.42M |
Net Cash | -94.98M |
Net Cash Per Share | -0.18 |
Equity (Book Value) | 217.87M |
Book Value Per Share | 0.40 |
Working Capital | 63.53M |
Cash Flow
In the last 12 months, operating cash flow was 31.41 million and capital expenditures -696,000, giving a free cash flow of 30.71 million.
Operating Cash Flow | 31.41M |
Capital Expenditures | -696,000 |
Free Cash Flow | 30.71M |
FCF Per Share | 0.06 |
Margins
Gross margin is 58.12%, with operating and profit margins of 23.56% and -18.34%.
Gross Margin | 58.12% |
Operating Margin | 23.56% |
Pretax Margin | -27.01% |
Profit Margin | -18.34% |
EBITDA Margin | 27.80% |
EBIT Margin | 23.56% |
FCF Margin | 17.00% |
Dividends & Yields
Alliance Pharma does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | 5.03% |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -0.12% |
Shareholder Yield | -0.12% |
Earnings Yield | -14.35% |
FCF Yield | 13.29% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |